Company: XERI
Filing Date: 2025-10-02
Form Type: 10-K
Source: 0001477932-25-007303
Chunk: 750

Company: XERIANT, INC.
Filing Date: 2025-10-02
Form: 10-K
Item: Item 8
Chunk 750
---
(40,899 )  -   -   -   40,899,000   409   -   (409)  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   107,738,888   1,078   45,950   1,034,023   -   -   1,081,051                                              Warrants associated with convertible debt  -   -   -   -   -   -   -   35,212   -   -   35,212                                              Cashless exercise of warrants  -   -   -   -   1,528,185   15   -   (15)  -   -   -                                              Net Loss  -   -   -   -   -   -   -   -   (1,629,691 )  (17,207 )  (1,646,898 )                                             Balance June 30, 2025  664,996  $7   1,000,000  $10   695,746,625  $6,958  $97,900  $22,410,416  $(28,338,606 ) $(2,877,148 ) $(8,700,463 )

The accompanying notes are an integral part of these consolidated financial statements.

 F-5Table of Contents

XERIANT, INC. 

CONSOLIDATED STATEMENTS OF CASH FLOWS

  For the years ended   June 30,   2025  2024        Cash Flows from Operating Activities      Net loss $(1,646,898) $(3,103,101)Adjustments to reconcile net loss to net cash used by operating activities:        Depreciation and amortization  1,599   1,512 Stock issued for services  442,626   374,906 Loss on extinguishment of debt  4,835   20,